Discontinuation of antipsychotic medication-time to rethink trial design
| Autor: | Nikolai Albert, Iris E. C. Sommer, Wim Veling, Marieke J. H. Begemann, Eoin Killackey, Merete Nordentoft, Amber Weller, Kelly Allott, Helene Speyer |
|---|---|
| Přispěvatelé: | Clinical Cognitive Neuropsychiatry Research Program (CCNP), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Movement Disorder (MD) |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Research design
medicine.medical_specialty Patient Dropouts business.industry medicine.medical_treatment Patient Selection MEDLINE Medication adherence Discontinuation Medication Adherence Psychiatry and Mental health Psychotic Disorders Recurrence Research Design Medicine Humans Psychotic Disorders/drug therapy business Intensive care medicine Antipsychotic Biological Psychiatry Antipsychotic Agents/therapeutic use Antipsychotic Agents Randomized Controlled Trials as Topic |
| Zdroj: | The Lancet. Psychiatry, 7(10), 841-842. ELSEVIER SCI LTD |
| ISSN: | 2215-0374 2215-0366 |
| DOI: | 10.1016/S2215-0366(20)30340-0 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|